Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO Italy 2020 | Treatment approaches to CLL

Alessandra Ferrajoli • 17 Sep 2020
SOHO Italy 2020
Chronic Lymphocytic Leukemia Leukemia

Alessandra Ferrajoli, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses approaches to the treatment of patients with chronic lymphocytic leukemia (CLL), including front-line and relapsed disease as well as the role of immunotherapy and targeted agents. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Alessandra Ferrajoli

0:59
Mitigating cardiological toxicities associated with BTKi in B-cell malignancies
Alessandra Ferrajoli • 11 Dec 2023
1:22
Does acalabrutinib increase the risk of hypertension in patients with CLL?
Alessandra Ferrajoli • 11 Dec 2023
1:22
The role of ibrutinib in CLL and important adverse events to consider with the use of this agent
Alessandra Ferrajoli • 7 Sep 2023
1:12
Insights into the optimal management of CLL: the importance of patient characteristics
Alessandra Ferrajoli • 7 Sep 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals